EVMS Dept. of Psychiatry & Behavioral Sciences: Stephen Deutsch, MD, PhD, Chairman

Faculty - Biography

Deutsch-99845550

Stephen I. Deutsch, MD, PhD
Chair & Professor

825 Fairfax Avenue
Hofheimer Hall
Norfolk, VA 23507
Phone: (757) 446-5888
Fax: (757) 446-5918
Email contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Selected Professional Experience and Academic Appointments

Ann Robinson Endowed Chair in Psychiatry, Professor and Chair, EVMS Department of Psychiatry and Behavioral Sciences, (July 2009-present)
Associate Chief of Staff for Mental Health, Department of Veterans Affairs Medical Center, Washington, DC (2005-2009)
Professor of Psychiatry, Uniformed Services University School of Medicine, Bethesda, Maryland (2004-present)
Professor of Psychiatry, Georgetown University School of Medicine, Washington, DC (1990-present)
Professor of Psychiatry, Howard University School of Medicine, Washington, DC (2005-2009)
Associate Chairman and Director of the Division of Clinical Neurosciences, Department of Psychiatry, Georgetown University School of Medicine, Washington, DC (1987-2009)

Education

MD, New York University School of Medicine, 1977
PhD, Biochemical Pharmacology, New York University, 1977
Internship, Neurology and Psychiatry, New York Veterans Administration Medical Center, NY, 1978
Residency, Psychiatry, Bellevue Psychiatric Hospital – New York University Medical Center, NY, 1981
Fellowship, Child Psychiatry, New York University Medical Center – Bellevue Psychiatric Hospital, 1985
Fellowship, Pharmacology Research Associate, National Institute of Health – Clinical Neurosciences Branch, NIMH, 1987

Board Certifications and Licensure

Licensure: District of Columbia, Maryland, New York, and Virginia
Diplomate, American Board of Psychiatry and Neurology (1982)

Selected Awards and Honors

Fellow, American College of Neuropsychopharmacology (ACNP)
The Army Commendation Medal, Department of the Army, April, 2009
Award of Excellence in Teaching, USUHS Department of Psychiatry, 2008

Selected Memberships

Associate Editor, Clinical Neuropharmacology
Editorial Board Member, Progress in Neuro-Psychopharmacology & Behavioral Psychology (2009-present)
Member and Co-Chair, Constitution and Rules Committee, American College of Neuropsychopharmacology (ACNP) (2007-2009)

Professional/Clinical Interests

Translational applications of developments in basic neuroscience to the diagnosis and treatment of patients with neuropsychiatric disorders.

Recent Grants and Funding Awards

Principal Investiragor (2010-2011). Outcomes and neuropsychological correlates of enlarged and/or asymmetric cerebral ventricles in the fetus. Project funded for $21,500 through The Norfolk Foundation.

Principal Investiragor (2010). Outcomes and neuropsychological correlates of fetal ultrasounds. Project funded for $21,500 through The Norfolk Foundation.

Principal Investigator (2009-2011). Intervention to test the Alpha 7 nicotinic receptor model in schizophrenia. Project funded for $150,484 through R34 Clinical Trial Planning Grant.

Principal Investigator, NIH RMH077849A (2007-2010). Intervention to test the Alpha 7 nicotinic receptor. Project funded for $628,560 through R34 Clinical Trial Planning Grant.

Recent Publications

Ball, J.D., Deutsch, S.I., Abuhamad, A.Z., Katz, E., Mason, J., & Becket, J. (Under Review). Mild isolated cerebral ventriculomegaly on fetal ultrasound: Support for nonverbal learning disability. Pediatrics.

Deutsch, S.I., Burket, J.A., Rosse, R.B., & Schwartz, B.L. (2009). Genetic Variation of Chromosome 1q42: Etiologic mechanism of congenital disorders of neuronal migration and synaptogenesis. Current Psychiatry Reviews, 5, 236-249.

Deutsch, S.I., Mastropaolo, J., Burket, J.A., & Rosse, R.B. (2009). An epigenetic intervention interacts with genetic strain differences to modulate the stress-induced reduction of flurazepam’s antiseizure efficacy in the mouse. European Neuropsychopharmacology, 19(6), 398-401.

Deutsch, S.I., Rosse, R.B., Schwartz, B.L., Mastropaolo, J., Burket, J.A., & Weizman, A. (in press). Impaired inhibitory regulation of intermittent oscillations of assemblies of pyramidal neurons underlies disturbances of working memory and higher executive functions in schizophrenia: Rational for pharmacotherapeutic GABAergic interventions. Israel Journal of Psychiatry.

Deutsch, S.I., Rosse, R.B., Sud, I.M., & Burket, J.A. (2009). Temporal lobe epilepsy confused with panic disorder: Implications for treatment. Clinical Neuropharmacology, 32(3), 160-162.

Schwartz, B.L., Parker, E.S., Rosse, R.B., & Deutsch, S.I. (2009). Recognition memory probes affect what is remembered in schizophrenia. Psychiatry Research, 167, 21–27.

Burket, J.A., Mastropaolo, J., Rosse, R.B., & Deutsch, S.I. (2010). Genetically-inbred Balb/C mice are more sensitive to an effect of Flurazepam and more resistant to an effect of stress than a genetically-outbred mouse strain. Epilepsy & Behavior, 16(3), 415-417.

Deutsch, S.I., Burket, J.A., & Rosse, R.B. (in press). Valproate-induced hyperammonemic encephalopathy and normal liver functions: Possible synergism with topiramate. Clinical Neuropharmacology.

Katz, E., Burket, J.A., Rosse, S.M., Rosse, R.B., Schwartz, B.L., & Deutsch, S.I. (2010). Cerebral ventricular asymmetry and ventriculomegaly interact to increase risk for schizophrenia: A case report and recommendation for routine fetal sonography. CNS Spectrums, 15(9), 522-526.

Burket, J.A., Mastropaolo, J., Rosse, R.B., Katz, E.U., & Deutsch, S.I. (2010). NMDA NR2B subtype-selective receptor antagonists fail to antagonize electreically-precipitated seizures and elicit popping in mice. Eur Neuropsychopharmacol, 20(3), 207-210.

Deutsch, S. I., Urbano, M. R., Neumann, S. A., Burket, J. A., & Katz, E. (in press). Cholinergic abnormalities in autism: Is there a rational for selective nicotinic agonist interventions? Clin Neuropharmacol.

Deutsch, S.I., Burket, J.A., & Katz, E. (2010). Does subtle disturbance of neuronal migration contribute to schizophrenia and other neurodevelopmental disorders? Potential genetic mechanisms with possible treatment implications. Eur Neuropsychopharmacol, 20(5), 281-287.

Schwartz, B.L., Vaidya, C.J., Howard, J.H, Jr., & Deutsch, S.I. (in press). Attention to gaze and emotion in schizophrenia. Neuropsychology.

Deutsch, S.I. (2010). The Mental Status Exam in Talmudic medicine. CNS Spectrums, 15(7), 216-217.

Burket, J.A., Herndon, A.L., & Deutsch, S.I. (2010). Locomotor activity of the genetically-inbred balb/c mouse strain is suppressed by a socially-salient stimulus. Brain Research Bulletin, 83, 255-256.

Burket, J.A., Cannon, W.R., Jacome, L.F., & Deutsch, S.I. (in press). MK-801, a noncompetitive NMDA receptor antagonist, elicited circling behavior in the genetically-inbred balb/c mouse strain. Brain Research Bulletin.

Deutsch, S.I., Burket, J.A., Jacome, L.F., Cannon, W.R., & Herndon, A.L. (in press). D-Cycloserine improves the impaired sociability of the balb/c mouse. Brain Research Bulletin.

Jacome, L.F., Burket, J.A., Herndon, A.L.,Cannon, W.R., & Deutsch, S.I. (in press). D-serine improves dimensions of the sobiability deficit of the genetically-inbred balb/c mouse strain. Brain Research Bulletin.

Jacome, L.F., Burket, J.A., Herndon, A.L., & Deutsch, S.I. (in press). D-Cycloserine enhances social exploration in the balb/c mouse. Brain Research Bulletin.

Deutsch, S.I., Burket, J.A., Cannon, W.R., & Jacome, L.F. (in press). Selective mGluR5 antagonism attenuates the stress-induced reduction of MK-801's antiseizure potency in the genetically-inbred balb/c mouse. Epilepsy & Behavior.

Recent Presentations

Deutsch, S. I. (February 2011). N-methyl-D-aspartate (NMDA) receptor physiology - Animal models of the social deficits of autism. Given at EVMS Sponsored Conference titled "Insights into Autism," Virginia Beach Resort Hotel and Conference Center, Virginia Beach, VA.

Burket J.A., Deutsch, S.I., Cannon, W.R., & Jacome, L.F. (December 2010). Selective mGluR5 antagonism attenuates the stress-induced reduction of MK-801’s antiseizure potency in the genetically-inbred Balb/c mouse. Poster presentation at the 49^th Annual Meeting of the American College of Neuropsychopharmacology, Miami Beach, FL.

Deutsch, S. I. (December 2010). Is the genetically-inbred Balb/c mouse with impaired sociability and altered NMDA receptor-mediated neurotransmission an animal model of autism spectrum disorder? Special presentation given as part of The Autism Spectrum Disorders Quarterly Educational Series, sponsored by Eastern Virginia Medical School Department of Psychiatry and Behavioral Sciences, Norfolk, VA.

Deutsch, S.I., Burket, J.A., Jacome, L., Cannon, W.R., & Herndon, A.L. (December 2010). D-Cycloserine improves the impaired sociability of the Balb/c mouse. Poster presentation at the 49^th Annual Meeting of the American College of Neuropsychopharmacology, Miami Beach, FL.

Schwartz, B., Vaidya, C., Howard, J., Jr., & Deutsch, S. (December 2010). Implicit learning of socio-emotional stimuli in schizophrenia: behavioral and fMRI findings. Poster presentation at the 49^th Annual Meeting of the American College of Neuropsychopharmacology, Miami Beach, FL.

Deutsch, S. I. (September 2010). Managing the depressed patient, depression and diabetes: Reciprocal interactions, implications for management and effects on outcome. Seminar presented at the Turning the Tide on Diabetes Conference 2010, Virginia Beach, Virginia.

Deutsch, S. I. (May 2010). Practical Guide to the Performance of the Mental Status Examination. Seminar presented at the Annual Meeting of the American Psychiatric Association, New Orleans, LA.

Deutsch, S. I. (May 2010). Presentation of a Clinical Case Conference on Schizophrenia to Graduate Students and Faculty, Inter-Departmental Program in Neuroscience, Georgetown University School of Medicine, Washington, DC.

Deutsch, S. I. (October 2009). Pharmacology of Sleep, Wake, and Arousal. Special lecture to residents in Psychiatry at the Eastern Virginia Medical School, Norfolk, VA.

Deutsch, S. I. (October 2009). Schizophrenia: Descriptive, Psychopathological, and Genetic Considerations. Grand Rounds Presentation to the Department of Psychiatry, Portsmouth Naval Medical Hospital, Portsmouth, VA.

Deutsch, S. I. (August 2009). Beyond the Agonist Recognition Site: Allosteric Modulatory and Other Pharmacotherapeutic Strategies for Neuropsychiatric Disorders. Grand Rounds Presentations to the Departments of Psychiatry, EVMS; the Department of Endocrinology, EVMS; and the Department of Psychiatry, Portsmouth Naval Medical Hospital.

Top

Last Updated on Thursday, 17 November 2011 13:19